Nulixir Inc.

United States of America

Back to Profile

1-41 of 41 for Nulixir Inc. Sort by
Query
Aggregations
IP Type
        Patent 31
        Trademark 10
Jurisdiction
        United States 29
        World 6
        Canada 4
        Europe 2
Date
2025 2
2024 3
2023 19
2022 7
2021 10
IPC Class
A61K 9/51 - Nanocapsules 23
A61K 9/00 - Medicinal preparations characterised by special physical form 15
A23L 33/155 - Vitamins A or D 13
A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir 13
A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate 13
See more
NICE Class
01 - Chemical and biological materials for industrial, scientific and agricultural use 7
42 - Scientific, technological and industrial services, research and design 2
05 - Pharmaceutical, veterinary and sanitary products 1
Status
Pending 21
Registered / In Force 20

1.

PARTICLES FOR DELIVERY OF SUBSTANCES

      
Application Number US2025024621
Publication Number 2025/221702
Status In Force
Filing Date 2025-04-14
Publication Date 2025-10-23
Owner NULIXIR INC. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a nanoparticle including: a solid core comprising an active ingredient, a wax, and a carrier oil; a first shell surrounding the core, wherein the first shell comprises one or more proteins and one or more carbohydrates; and a second shell surrounding the first shell.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 31/59 - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems
  • A61K 36/80 - Scrophulariaceae (Figwort family)
  • A61K 36/258 - Panax (ginseng)
  • A61K 31/221 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
  • A23P 10/30 - Encapsulation of particles, e.g. foodstuff additives
  • A23P 20/20 - Making of laminated, multi-layered, stuffed or hollow foodstuffs, e.g. by wrapping in preformed edible dough sheets or in edible food containers

2.

FUNCTION LAB

      
Serial Number 99394360
Status Pending
Filing Date 2025-09-16
Owner Nulixir, Inc. (USA)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Product development in the field of foods, beverages, soft drinks, dietary supplements, nutritional supplements, flavorings, and ingredients for use in foods, beverages, soft drinks, dietary supplements, and nutritional supplements

3.

WATER SOLUBLE COMPOSITIONS AND METHODS OF MAKING THE SAME

      
Application Number 18611516
Status Pending
Filing Date 2024-03-20
First Publication Date 2024-11-21
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a composition for oral administration, the composition including: a dispersion medium including: an aqueous solution; and a dispersed phase including: a population of particles, each particle including: a core including: a first active ingredient; and an aqueous solution; a shell, substantially surrounding the core, the shell including: a lipophilic carrier; and a plurality of emulsifying agents; wherein the particle retards the release of the first active ingredient after consumption.

IPC Classes  ?

  • A61K 9/10 - DispersionsEmulsions
  • A23L 29/10 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing emulsifiers
  • A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
  • A23L 33/155 - Vitamins A or D
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/08 - Solutions
  • A61K 9/107 - Emulsions
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/50 - Microcapsules
  • A61K 9/51 - Nanocapsules
  • A61K 31/05 - Phenols
  • A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 35/741 - Probiotics
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 36/06 - Fungi, e.g. yeasts
  • A61K 36/062 - Ascomycota
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/41 - Crassulaceae (Stonecrop family)
  • A61K 36/53 - Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
  • A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
  • A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
  • A61K 36/67 - Piperaceae (Pepper family), e.g. Jamaican pepper or kava
  • A61K 36/68 - Plantaginaceae (Plantain Family)
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

4.

ENCAPSULATED VITAMIN D

      
Application Number 18447240
Status Pending
Filing Date 2023-08-09
First Publication Date 2024-05-23
Owner NULIXIR INC. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided are thermodynamically stable particles encapsulating active ingredients for administering to humans and other living organisms.

IPC Classes  ?

  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3

5.

NUD3

      
Serial Number 98517461
Status Pending
Filing Date 2024-04-24
Owner Nulixir Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Vitamins

6.

ENCAPSULATED PRECURSORS OF NICOTINAMIDE ADENINE DINUCLEOTIDE AND METHODS OF MAKING THE SAME

      
Application Number 18168394
Status Pending
Filing Date 2023-02-13
First Publication Date 2023-12-21
Owner Nulixir Inc. (USA)
Inventor
  • Moaseri, Ehsan
  • Cahoon, Collin Ryan
  • Bender, Jon Alexander

Abstract

Provided is a composition including a dispersion medium including: an aqueous solution and a dispersed phase including a population of particles, each particle including an active ingredient.

IPC Classes  ?

  • A23L 33/15 - Vitamins
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom

7.

NUSOMES

      
Application Number 018951203
Status Registered
Filing Date 2023-11-15
Registration Date 2024-03-13
Owner Nulixir Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Chemicals for use in industry and science, as well as in agriculture, horticulture and forestry; Chemicals for use in manufacture; Biological preparations for use in industry and science; Biological preparations for use in manufacture; Antioxidants used in the manufacture of beverages, food products, and food supplements; enzymes for use in the manufacture of nutraceuticals, beverages, and food products; enzymes for food or drinks; vitamins for use in the manufacture of beverages and food supplements; vitamins for the food industry; proteins for use in the manufacture of beverages and food supplements; chemical additives for use in the manufacture of food, beverages, food supplements, and beverage supplements; proteins used in the manufacture of beverages, food products, and food supplements; microbes for use in the manufacture of probiotic supplements and food for humans; probiotic bacteria for the food industry.

8.

NUSOMES

      
Application Number 229265600
Status Registered
Filing Date 2023-11-14
Registration Date 2026-02-09
Owner Nulixir Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

(1) Antioxidants used in the manufacture of beverages, food products, and food supplements; enzymes for use in the manufacture of nutraceuticals, beverages, and food products; vitamins for use in the manufacture of beverages and food supplements; proteins for use in the manufacture of beverages food supplements; chemical additives for use in the manufacture of food and beverage supplements; proteins used in the manufacture of beverages, food products, and food supplements; microbes for use in the manufacture of probiotic supplements and food for humans.

9.

NUSOMES

      
Serial Number 98264645
Status Pending
Filing Date 2023-11-10
Owner Nulixir Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Antioxidants used in the manufacture of beverages, food products, and food supplements; enzymes for use in the manufacture of nutraceuticals, beverages, and food products; vitamins for use in the manufacture of beverages and food supplements; proteins for use in the manufacture of beverages food supplements; chemical additives for use in the manufacture of food and beverage supplements; proteins used in the manufacture of beverages, food products, and food supplements; microbes for use in the manufacture of probiotic supplements and food for humans

10.

ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME

      
Application Number 17945011
Status Pending
Filing Date 2022-09-14
First Publication Date 2023-05-25
Owner Nulixir Inc. (USA)
Inventor
  • Moaseri, Ehsan
  • Cahoon, Collin R.
  • Bender, Jon A.

Abstract

Provided is a process, including: extracting one or more hydrophobic active ingredients of a plant material using an extraction solvent; transferring the one or more hydrophobic active ingredients from the extraction solvent to a carrier solvent; encapsulating the one or more hydrophobic active ingredients in one or more nanoparticles; and dispersing the one or more nanoparticles in an aqueous suspension, wherein: the one or more nanoparticles have a Z-average diameter between 50 to 950 nanometers; the Z-average diameter of the one or more nanoparticles changes less than 20% when the aqueous suspension is incubated at 40° C. for four weeks; and the Z-average diameter of the one or more nanoparticles changes less than 20% when the aqueous suspension is incubated at 90° C. for 30 minutes.

IPC Classes  ?

11.

SOLID ORAL BEADS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME

      
Application Number 17944985
Status Pending
Filing Date 2022-09-14
First Publication Date 2023-05-25
Owner Nulixir Inc. (USA)
Inventor
  • Moaseri, Ehsan
  • Cahoon, Collin R.

Abstract

Provided is a bead for use in food or a beverage, the bead comprising: a core comprising: a continuous phase comprising: a lipophilic carrier, and a wax; a dispersed phase comprising: one or more particles, wherein each particle comprises: a first active ingredient, and a first polymer, and a first shell at least substantially surrounding the core.

IPC Classes  ?

  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

12.

ORAL COMPOSITIONS OF PLANTS THROUGH A DOUBLE EXTRACTION SYSTEM AND METHODS OF MAKING THE SAME

      
Application Number 17944982
Status Pending
Filing Date 2022-09-14
First Publication Date 2023-05-18
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a process, including: extracting one or more hydrophobic active ingredients of a plant material using a first extraction solvent; and transferring the one or more hydrophobic active ingredients from the first extractant solution filtrate to a carrier solvent; encapsulating the one or more hydrophobic active ingredients in one or more nanoparticles; dispersing the one or more nanoparticles in an aqueous suspension; and adding the second eluant from the plant material to the aqueous suspension.

IPC Classes  ?

  • B01D 11/02 - Solvent extraction of solids
  • A61K 9/51 - Nanocapsules
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • B01D 37/00 - Processes of filtration
  • B01D 21/26 - Separation of sediment aided by centrifugal force

13.

STABLE COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME

      
Application Number 17945010
Status Pending
Filing Date 2022-09-14
First Publication Date 2023-04-13
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a composition, including: an aqueous suspension, comprising: a first plurality of active ingredients, and one or more nanoparticles, wherein: the one or more nanoparticles encapsulate a second plurality of active ingredients; the second plurality of active ingredients are insoluble in the aqueous suspension; the one or more nanoparticles solubilize the second plurality of active ingredients in the aqueous suspension; and the one or more nanoparticles have a Z-average diameter between 50 to 950 nanometers.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/67 - Piperaceae (Pepper family), e.g. Jamaican pepper or kava
  • A61K 36/53 - Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
  • A61K 36/9068 - Zingiber, e.g. garden ginger
  • A61K 36/258 - Panax (ginseng)
  • A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
  • A61K 36/481 - Astragalus (milkvetch)
  • A61K 36/07 - Basidiomycota, e.g. Cryptococcus
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/88 - Liliopsida (monocotyledons)
  • A61K 31/05 - Phenols
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 31/60 - Salicylic acidDerivatives thereof
  • A61K 31/343 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
  • A61K 31/4458 - Non-condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
  • A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 31/465 - NicotineDerivatives thereof
  • A61K 31/165 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
  • A61K 36/37 - Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
  • A61K 31/4025 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
  • A61K 31/13 - Amines, e.g. amantadine
  • A61K 36/23 - Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin

14.

STABLE FORMULATIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME

      
Application Number 17945035
Status Pending
Filing Date 2022-09-14
First Publication Date 2023-04-13
Owner Nulixir Inc. (USA)
Inventor
  • Moaseri, Ehsan
  • Cahoon, Collin R.
  • Bender, Jon A.

Abstract

Provided is a process including: extracting a first plurality of active ingredients of a first plant material using a first extraction solvent; extracting a second plurality of active ingredients of a second plant material using a second extraction solvent; transferring the first plurality of active ingredients from the first extractant solution filtrate to a carrier solvent; encapsulating the first plurality of active ingredients in one or more nanoparticles; dispersing the one or more nanoparticles in an aqueous suspension; and adding the second eluant from the second plant material to the aqueous suspension.

IPC Classes  ?

  • A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
  • A61Q 19/00 - Preparations for care of the skin
  • B01D 11/02 - Solvent extraction of solids
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 9/14 - Particulate form, e.g. powders

15.

MULTI-LAYER PARTICLES OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME

      
Application Number 17945001
Status Pending
Filing Date 2022-09-14
First Publication Date 2023-04-13
Owner Nulixir Inc. (USA)
Inventor
  • Moaseri, Ehsan
  • Cahoon, Collin R.

Abstract

Provided is an additive for food, a beverage, or a supplement, the additive comprising: a first phase comprising: a first filler and a second phase, the second phase comprising a second filler and a third phase, the third phase comprising a third filler and a fourth phase, the fourth phase comprising a fifth filler and a first active ingredient.

IPC Classes  ?

  • A23P 20/20 - Making of laminated, multi-layered, stuffed or hollow foodstuffs, e.g. by wrapping in preformed edible dough sheets or in edible food containers
  • A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives

16.

ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME

      
Application Number 17945038
Status Pending
Filing Date 2022-09-14
First Publication Date 2023-04-13
Owner Nulixir Inc. (USA)
Inventor
  • Moaseri, Ehsan
  • Cahoon, Collin R.
  • Bender, Jon A.

Abstract

Provided is an aqueous solution as a continuous phase, the aqueous solution comprising: a first plurality of polymers; and a first plurality of active ingredients; and one or more nanoparticles, as a dispersed phase, the one or more nanoparticles comprising: a first plurality of carrier solvents; and a second plurality of active ingredients, wherein: the second plurality of active ingredients have at least 5 times higher absorption in-vivo when located inside the one or more nanoparticles compared to when administered in an aqueous solution.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 31/05 - Phenols
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 31/12 - Ketones
  • A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
  • A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
  • A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
  • A61K 31/194 - Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
  • A61K 31/575 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
  • A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

17.

STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME

      
Application Number US2022043549
Publication Number 2023/043852
Status In Force
Filing Date 2022-09-14
Publication Date 2023-03-23
Owner NULIXIR INC. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided are thermodynamically stable particles encapsulating active ingredients for administering to humans and other living organisms.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 9/50 - Microcapsules
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A23P 10/30 - Encapsulation of particles, e.g. foodstuff additives

18.

ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME

      
Application Number US2022043550
Publication Number 2023/043853
Status In Force
Filing Date 2022-09-14
Publication Date 2023-03-23
Owner NULIXIR INC. (USA)
Inventor
  • Moaseri, Ehsan
  • Cahoon, Collin R.
  • Bender, Jon A.

Abstract

Provided are thermodynamically stable particles encapsulating active ingredients for administering to humans and other living organisms.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 9/50 - Microcapsules
  • A23P 10/30 - Encapsulation of particles, e.g. foodstuff additives
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 9/00 - Medicinal preparations characterised by special physical form

19.

ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS

      
Application Number US2022043551
Publication Number 2023/043854
Status In Force
Filing Date 2022-09-14
Publication Date 2023-03-23
Owner NULIXIR INC. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided are thermodynamically stable particles encapsulating active ingredients for administering to humans and other living organisms.

IPC Classes  ?

20.

ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS

      
Document Number 03231913
Status Pending
Filing Date 2022-09-14
Open to Public Date 2023-03-23
Owner NULIXIR INC. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided are thermodynamically stable particles encapsulating active ingredients for administering to humans and other living organisms.

IPC Classes  ?

21.

ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME

      
Application Number US2022043552
Publication Number 2023/043855
Status In Force
Filing Date 2022-09-14
Publication Date 2023-03-23
Owner NULIXIR INC. (USA)
Inventor
  • Moaseri, Ehsan
  • Cahoon, Collin R.
  • Bender, Jon A.

Abstract

Provided are thermodynamically stable particles encapsulating active ingredients for administering to humans and other living organisms.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 9/50 - Microcapsules
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 9/00 - Medicinal preparations characterised by special physical form

22.

STABLE NON-AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME

      
Application Number 17945036
Status Pending
Filing Date 2022-09-14
First Publication Date 2023-03-16
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a process including: extracting a first plurality of active ingredients of a first plant material using an extraction solvent, wherein the extraction comprises: transferring the first plant material into a temperature-controlled reactor, adding the extraction solvent to the temperature-controlled reactor, thereby producing a first eluant from the first plant material, incubating the first eluant at a first selected temperature for a first duration of time, applying ultrasound waves on the first plant material to expedite the extraction of the first plurality of active ingredients of the first plant material, and running the first eluent through a filtration process to obtain a first extractant solution filtrate and a first separated solid plan material product; encapsulating the first plurality of active ingredients in one or more nanoparticles; and dispersing the first plurality of active ingredients in a non-aqueous suspension.

IPC Classes  ?

23.

STABLE AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME

      
Application Number 17945012
Status Pending
Filing Date 2022-09-14
First Publication Date 2023-03-16
Owner Nulixir Inc. (USA)
Inventor
  • Moaseri, Ehsan
  • Cahoon, Collin R.
  • Bender, Jon A.

Abstract

Provided is a process of stabilizing active ingredients of plant materials in an aqueous suspension, the process including: extracting one or more active ingredients of a plant material using an extraction solvent, wherein the extraction of the one or more active ingredients of the plant materials comprises: transferring the plant material into a temperature-controlled reactor; adding the extraction solvent to the temperature-controlled reactor, thereby producing an eluant from the plant material; incubating the eluant at a first selected temperature for a pre-determined duration of time; and running the eluent through a filtration process to obtain an extractant solution filtrate and a separated solid plan material product; encapsulating the one or more active ingredients in one or more nanoparticles; and dispersing the one or more nanoparticles in an aqueous suspension.

IPC Classes  ?

  • A61K 9/10 - DispersionsEmulsions
  • A61K 8/04 - DispersionsEmulsions
  • A61Q 19/00 - Preparations for care of the skin
  • A61K 9/51 - Nanocapsules
  • A61K 8/65 - CollagenGelatinKeratinDerivatives or degradation products thereof
  • A61K 8/60 - SugarsDerivatives thereof
  • B01D 11/02 - Solvent extraction of solids
  • B01D 21/26 - Separation of sediment aided by centrifugal force
  • B01D 37/00 - Processes of filtration
  • A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
  • A23P 10/30 - Encapsulation of particles, e.g. foodstuff additives

24.

STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME

      
Application Number 17945037
Status Pending
Filing Date 2022-09-14
First Publication Date 2023-03-16
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a non-aqueous suspension, comprising: a first plurality of active ingredients, wherein: the first plurality of active ingredients are soluble in the non-aqueous suspension; and one or more nanoparticles, wherein: the one or more nanoparticles encapsulate a second plurality of active ingredients; the second plurality of active ingredients are insoluble in the non-aqueous suspension; the one or more nanoparticles solubilize the second plurality of active ingredients in the non-aqueous suspension; the one or more nanoparticles have a Z-average diameter between 50 to 950 nanometers; the Z-average diameter of the one or more nanoparticles changes less than 20% when the non-aqueous suspension is incubated at 40° C. for four weeks; and the Z-average diameter of the one or more nanoparticles changes less than 20% when the non-aqueous suspension is incubated at 90° C. for 30 minutes.

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/51 - Nanocapsules
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
  • A23P 10/30 - Encapsulation of particles, e.g. foodstuff additives

25.

FUNCTION HOUSE

      
Serial Number 97726899
Status Pending
Filing Date 2022-12-21
Owner Nulixir Inc. (USA)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Product development in the fields of foods, beverages, soft drinks, dietary supplements, nutritional supplements, flavorings, and ingredients for use in foods, beverages, soft drinks, dietary supplements, and nutritional supplements

26.

Controlled release core-shell particles and suspensions including the same

      
Application Number 17854297
Grant Number 12485091
Status In Force
Filing Date 2022-06-30
First Publication Date 2022-10-20
Grant Date 2025-12-02
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a composition including a dispersion medium including: an aqueous solution; a first active ingredient; a flavor agent; and a first type of polymer; and a dispersed phase including: a population of particles, each particle including: a core including: a second active ingredient a second type of polymer; and an aqueous solution; a shell, substantially surrounding the core, the shell including: a third type of polymer; a plurality of lipophilic carriers; and a third active ingredient; and a plurality of emulsifying agents.

IPC Classes  ?

  • A61K 9/10 - DispersionsEmulsions
  • A23L 2/00 - Non-alcoholic beveragesDry compositions or concentrates thereforPreparation or treatment thereof
  • A23L 27/00 - SpicesFlavouring agents or condimentsArtificial sweetening agentsTable saltsDietetic salt substitutesPreparation or treatment thereof
  • A23L 29/00 - Foods or foodstuffs containing additivesPreparation or treatment thereof
  • A23L 29/10 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing emulsifiers
  • A23L 29/20 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents
  • A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
  • A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
  • A23L 33/13 - Nucleic acids or derivatives thereof
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
  • A23L 33/155 - Vitamins A or D
  • A23P 10/30 - Encapsulation of particles, e.g. foodstuff additives
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/08 - Solutions
  • A61K 9/107 - Emulsions
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 9/30 - Organic coatings
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/50 - Microcapsules
  • A61K 9/51 - Nanocapsules
  • A61K 31/00 - Medicinal preparations containing organic active ingredients
  • A61K 31/05 - Phenols
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 35/741 - Probiotics
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 36/06 - Fungi, e.g. yeasts
  • A61K 36/062 - Ascomycota
  • A61K 36/09 - Lichens
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/41 - Crassulaceae (Stonecrop family)
  • A61K 36/53 - Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
  • A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
  • A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
  • A61K 36/67 - Piperaceae (Pepper family), e.g. Jamaican pepper or kava
  • A61K 36/68 - Plantaginaceae (Plantain Family)
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • B01J 13/06 - Making microcapsules or microballoons by phase separation
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

27.

THE FUTURE OF INTELLIGENT FOOD

      
Serial Number 97629296
Status Pending
Filing Date 2022-10-12
Owner Nulixir Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Antioxidants and proteins used in the manufacture of beverages, food products, and food supplements; Enzymes for use in the manufacture of nutraceuticals, beverages, and food products; Vitamins for use in the manufacture of beverages and food supplements; Proteins for use in the manufacture of beverages and food supplements; Microbes for use in the manufacture of probiotic supplements and food for humans; Chemical additives for use in the manufacture of food and beverage supplements

28.

Water soluble compositions and methods of making the same

      
Application Number 17698896
Grant Number 11964049
Status In Force
Filing Date 2022-03-18
First Publication Date 2022-07-07
Grant Date 2024-04-23
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a composition for oral administration, the composition including: a dispersion medium including: an aqueous solution; and a dispersed phase including: a population of particles, each particle including: a core including: a first active ingredient; and an aqueous solution; a shell, substantially surrounding the core, the shell including: a lipophilic carrier; and a plurality of emulsifying agents; wherein the particle retards the release of the first active ingredient after consumption.

IPC Classes  ?

  • A61K 9/10 - DispersionsEmulsions
  • A23L 29/10 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing emulsifiers
  • A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
  • A23L 33/155 - Vitamins A or D
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/08 - Solutions
  • A61K 9/107 - Emulsions
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/50 - Microcapsules
  • A61K 9/51 - Nanocapsules
  • A61K 31/05 - Phenols
  • A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 35/741 - Probiotics
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 36/06 - Fungi, e.g. yeasts
  • A61K 36/062 - Ascomycota
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/41 - Crassulaceae (Stonecrop family)
  • A61K 36/53 - Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
  • A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
  • A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
  • A61K 36/67 - Piperaceae (Pepper family), e.g. Jamaican pepper or kava
  • A61K 36/68 - Plantaginaceae (Plantain Family)
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

29.

NULIXIR

      
Application Number 018726760
Status Registered
Filing Date 2022-07-01
Registration Date 2022-11-09
Owner Nulixir Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Chemicals for use in industry and science; Biological preparations for use in industry and science; Antioxidants and proteins for use in the manufacture of beverages, food products, and food supplements; Enzymes for the food industry; Enzymes for food or drinks; Enzymes for use in the manufacture of nutraceuticals, beverages, and food products; Vitamins for the food industry; Vitamins for use in the manufacture of beverages, food products and food supplements; Chemical supplements for use in the manufacture of vitamins; Proteins for the food industry; Proteins for use in the manufacture of beverages, food products and food supplements; Microbes for use in the manufacture of probiotic supplements and food for humans; Probiotic bacteria for the food industry; Chemical substances for use as food ingredients; Chemical additives for food; Chemical additives for use in the manufacture of food and beverage supplements; Flavour enhancers for food.

30.

NULIXIR

      
Application Number 219464900
Status Registered
Filing Date 2022-06-28
Registration Date 2025-07-18
Owner Nulixir Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

(1) Antioxidants and proteins used in the manufacture of beverages, food products, and food supplements; Enzymes for use in the manufacture of nutraceuticals, beverages, and food products; Vitamins for use in the manufacture of beverages and food supplements; Proteins for use in the manufacture of beverages food supplements; Microbes for use in the manufacture of probiotic supplements and food for humans; Chemical additives for use in the manufacture of food and beverage supplements.

31.

METHODS AND SYSTEMS FOR FORMING MULTI-LAYERED PARTICLES

      
Application Number 17470994
Status Pending
Filing Date 2021-09-09
First Publication Date 2022-04-14
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a method of encapsulation, the method including: providing a first mixture; applying heat to the first mixture until the first mixture reaches a first temperature; providing a second mixture; applying heat to the second mixture until the second mixture reaches a second temperature; mixing the first mixture with the second mixture to obtain a third mixture; providing a fourth mixture; applying heat to the fourth mixture until the fourth mixture reaches a third temperature; mixing the third mixture with the fourth mixture to obtain a fifth mixture.

IPC Classes  ?

  • A61K 9/10 - DispersionsEmulsions
  • A61K 9/08 - Solutions
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A23L 33/155 - Vitamins A or D
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/107 - Emulsions
  • A61K 9/51 - Nanocapsules
  • A23L 29/10 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing emulsifiers
  • A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 9/50 - Microcapsules
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61K 35/741 - Probiotics
  • A61K 36/062 - Ascomycota
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/53 - Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
  • A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
  • A61K 36/68 - Plantaginaceae (Plantain Family)
  • A61K 31/05 - Phenols
  • A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 36/06 - Fungi, e.g. yeasts
  • A61K 36/41 - Crassulaceae (Stonecrop family)
  • A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
  • A61K 36/67 - Piperaceae (Pepper family), e.g. Jamaican pepper or kava

32.

Particles for administration of active ingredients and methods of making the same

      
Application Number 17020731
Grant Number 12350367
Status In Force
Filing Date 2020-09-14
First Publication Date 2021-09-09
Grant Date 2025-07-08
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a multilayer particle, the particle including: a core including: a first active ingredient; and a first polymer; a first shell, substantially surrounding the core, the first shell including: a second polymer; a second shell, substantially surrounding the first shell, the second shell including: a third polymer; and a plurality of emulsifying agents.

IPC Classes  ?

  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A23L 29/10 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing emulsifiers
  • A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
  • A23L 33/155 - Vitamins A or D
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/08 - Solutions
  • A61K 9/10 - DispersionsEmulsions
  • A61K 9/107 - Emulsions
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 9/50 - Microcapsules
  • A61K 9/51 - Nanocapsules
  • A61K 31/05 - Phenols
  • A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 35/741 - Probiotics
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 36/06 - Fungi, e.g. yeasts
  • A61K 36/062 - Ascomycota
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/41 - Crassulaceae (Stonecrop family)
  • A61K 36/53 - Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
  • A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
  • A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
  • A61K 36/67 - Piperaceae (Pepper family), e.g. Jamaican pepper or kava
  • A61K 36/68 - Plantaginaceae (Plantain Family)
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

33.

Methods and systems for forming layered solid particles

      
Application Number 17020690
Grant Number 11793753
Status In Force
Filing Date 2020-09-14
First Publication Date 2021-08-05
Grant Date 2023-10-24
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a method of encapsulation, the method including: providing a first mixture, the first mixture including: a first carrier; and a first active ingredient; applying heat to the first mixture until the first mixture reaches a first temperature; providing a second mixture, the second mixture including: a second carrier; and a first emulsifying agent; applying heat to the second mixture until the second mixture reaches a second temperature; mixing the first mixture with the second mixture to obtain a third mixture, wherein: the mixing is performed at a third temperature; and the third temperature is lower than the first temperature; and cooling the third mixture until the third mixture reaches a fourth temperature, wherein: the second carrier is in solid state at the fourth temperature.

IPC Classes  ?

  • A61K 9/50 - Microcapsules
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 35/741 - Probiotics
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/53 - Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
  • A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
  • A61K 36/062 - Ascomycota
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61K 36/68 - Plantaginaceae (Plantain Family)
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 9/10 - DispersionsEmulsions
  • A61K 9/08 - Solutions
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A23L 33/155 - Vitamins A or D
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/107 - Emulsions
  • A61K 9/51 - Nanocapsules
  • A23L 29/10 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing emulsifiers
  • A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 31/05 - Phenols
  • A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 36/06 - Fungi, e.g. yeasts
  • A61K 36/41 - Crassulaceae (Stonecrop family)
  • A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
  • A61K 36/67 - Piperaceae (Pepper family), e.g. Jamaican pepper or kava
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

34.

Controlled release concentrate and suspensions including the same

      
Application Number 17020692
Grant Number 12653782
Status In Force
Filing Date 2020-09-14
First Publication Date 2021-06-10
Grant Date 2026-06-16
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a food and beverage additive having enhanced water solubility, the additive including: an aqueous solution; a first plurality of polymers; a first particle including: a first plurality of lipophilic carriers; a first active ingredient; a first plurality of emulsifying agents; and a second plurality of polymers; wherein the first particle exhibits higher hydrophilicity compared to the first active ingredient; and wherein a plurality of the first particles are uniformly dispersed in the aqueous solution.

IPC Classes  ?

  • A61K 9/08 - Solutions
  • A23L 29/10 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing emulsifiers
  • A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
  • A23L 33/155 - Vitamins A or D
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/10 - DispersionsEmulsions
  • A61K 9/107 - Emulsions
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/50 - Microcapsules
  • A61K 9/51 - Nanocapsules
  • A61K 31/00 - Medicinal preparations containing organic active ingredients
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 35/741 - Probiotics
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 36/06 - Fungi, e.g. yeasts
  • A61K 36/062 - Ascomycota
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/41 - Crassulaceae (Stonecrop family)
  • A61K 36/53 - Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
  • A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
  • A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
  • A61K 36/67 - Piperaceae (Pepper family), e.g. Jamaican pepper or kava
  • A61K 36/68 - Plantaginaceae (Plantain Family)
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

35.

Water soluble compositions and methods of making the same

      
Application Number 17020729
Grant Number 11351117
Status In Force
Filing Date 2020-09-14
First Publication Date 2021-06-10
Grant Date 2022-06-07
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a composition for oral administration, the composition including: a dispersion medium including: an aqueous solution; and a dispersed phase including: a population of particles, each particle including: a core including: a first active ingredient; and an aqueous solution; a shell, substantially surrounding the core, the shell including: a lipophilic carrier; and a plurality of emulsifying agents; wherein the particle retards the release of the first active ingredient after consumption.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 9/10 - DispersionsEmulsions
  • A61K 9/08 - Solutions
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A23L 33/155 - Vitamins A or D
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/107 - Emulsions
  • A23L 29/10 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing emulsifiers
  • A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 9/50 - Microcapsules
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61K 35/741 - Probiotics
  • A61K 36/062 - Ascomycota
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/53 - Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
  • A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
  • A61K 36/68 - Plantaginaceae (Plantain Family)
  • A61K 31/05 - Phenols
  • A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 36/06 - Fungi, e.g. yeasts
  • A61K 36/41 - Crassulaceae (Stonecrop family)
  • A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
  • A61K 36/67 - Piperaceae (Pepper family), e.g. Jamaican pepper or kava
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

36.

Controlled release core-shell particles and suspensions including the same

      
Application Number 17162916
Grant Number 11446245
Status In Force
Filing Date 2021-01-29
First Publication Date 2021-05-27
Grant Date 2022-09-20
Owner NULIXIR INC. (USA)
Inventor Moaseri, Ehsan

Abstract

Ginkgo Biloba, Bacopa, Rhodiola Rosea, and combinations thereof.

IPC Classes  ?

  • A61K 9/10 - DispersionsEmulsions
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 9/08 - Solutions
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 8/9771 - Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A23L 33/155 - Vitamins A or D
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/107 - Emulsions
  • A61K 9/51 - Nanocapsules
  • A23L 29/10 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing emulsifiers
  • A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 9/50 - Microcapsules
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61K 35/741 - Probiotics
  • A61K 36/062 - Ascomycota
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 36/53 - Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
  • A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
  • A61K 36/68 - Plantaginaceae (Plantain Family)
  • A61K 31/05 - Phenols
  • A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
  • A61K 36/06 - Fungi, e.g. yeasts
  • A61K 36/41 - Crassulaceae (Stonecrop family)
  • A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
  • A61K 36/67 - Piperaceae (Pepper family), e.g. Jamaican pepper or kava
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

37.

NULIXIR

      
Serial Number 90978503
Status Registered
Filing Date 2021-04-05
Registration Date 2023-02-28
Owner Nulixir Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Antioxidants used in the manufacture of beverages, food products, and food supplements; Enzymes for use in the manufacture of nutraceuticals, beverages, and food products; Vitamins for use in the manufacture of beverages and food supplements; Proteins for use in the manufacture of beverages food supplements; Chemical additives for use in the manufacture of food and beverage supplements

38.

CONTROLLED RELEASE CORE-SHELL PARTICLES AND SUSPENSIONS INCLUDING THE SAME

      
Application Number US2020050772
Publication Number 2021/051105
Status In Force
Filing Date 2020-09-14
Publication Date 2021-03-18
Owner NULIXIR INC. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a composition including a dispersion medium including: an aqueous solution; a first active ingredient; a flavor agent; and a first type of polymer; and a dispersed phase including: a population of particles, each particle including: a core including: a second active ingredient a second type of polymer; and an aqueous solution; a shell, substantially surrounding the core, the shell including: a third type of polymer; a plurality of lipophilic carriers; and a third active ingredient; and a plurality of emulsifying agents.

IPC Classes  ?

  • A23P 10/30 - Encapsulation of particles, e.g. foodstuff additives
  • A23P 10/35 - Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
  • A23L 33/15 - Vitamins
  • A23L 33/155 - Vitamins A or D
  • A23L 29/00 - Foods or foodstuffs containing additivesPreparation or treatment thereof
  • A23L 29/20 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents
  • A23L 3/358 - Inorganic compounds
  • A23L 27/00 - SpicesFlavouring agents or condimentsArtificial sweetening agentsTable saltsDietetic salt substitutesPreparation or treatment thereof
  • A23L 2/00 - Non-alcoholic beveragesDry compositions or concentrates thereforPreparation or treatment thereof
  • B01J 13/06 - Making microcapsules or microballoons by phase separation

39.

CONTROLLED RELEASE CORE-SHELL PARTICLES AND SUSPENSIONS INCLUDING THE SAME

      
Document Number 03150979
Status Pending
Filing Date 2020-09-14
Open to Public Date 2021-03-18
Owner NULIXIR INC. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a composition including a dispersion medium including: an aqueous solution; a first active ingredient; a flavor agent; and a first type of polymer; and a dispersed phase including: a population of particles, each particle including: a core including: a second active ingredient a second type of polymer; and an aqueous solution; a shell, substantially surrounding the core, the shell including: a third type of polymer; a plurality of lipophilic carriers; and a third active ingredient; and a plurality of emulsifying agents.

IPC Classes  ?

  • A23B 2/788 - Inorganic compounds
  • A23L 2/00 - Non-alcoholic beveragesDry compositions or concentrates thereforPreparation or treatment thereof
  • A23L 27/00 - SpicesFlavouring agents or condimentsArtificial sweetening agentsTable saltsDietetic salt substitutesPreparation or treatment thereof
  • A23L 29/00 - Foods or foodstuffs containing additivesPreparation or treatment thereof
  • A23L 29/20 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents
  • A23L 33/15 - Vitamins
  • A23L 33/155 - Vitamins A or D
  • A23P 10/30 - Encapsulation of particles, e.g. foodstuff additives
  • A23P 10/35 - Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
  • B01J 13/06 - Making microcapsules or microballoons by phase separation

40.

Methods and systems for forming multi-layered particles

      
Application Number 17020697
Grant Number 11123291
Status In Force
Filing Date 2020-09-14
First Publication Date 2021-03-18
Grant Date 2021-09-21
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a method of encapsulation, the method including: providing a first mixture; applying heat to the first mixture until the first mixture reaches a first temperature; providing a second mixture; applying heat to the second mixture until the second mixture reaches a second temperature; mixing the first mixture with the second mixture to obtain a third mixture; providing a fourth mixture; applying heat to the fourth mixture until the fourth mixture reaches a third temperature; mixing the third mixture with the fourth mixture to obtain a fifth mixture.

IPC Classes  ?

  • A61K 9/10 - DispersionsEmulsions
  • A61K 9/08 - Solutions
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A23L 33/155 - Vitamins A or D
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/107 - Emulsions
  • A61K 9/51 - Nanocapsules
  • A23L 29/10 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing emulsifiers
  • A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 9/50 - Microcapsules
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61K 35/741 - Probiotics
  • A61K 36/062 - Ascomycota
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/53 - Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
  • A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
  • A61K 36/68 - Plantaginaceae (Plantain Family)
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

41.

Controlled release core-shell particles and suspensions including the same

      
Application Number 17020693
Grant Number 10945953
Status In Force
Filing Date 2020-09-14
First Publication Date 2021-03-16
Grant Date 2021-03-16
Owner Nulixir Inc. (USA)
Inventor Moaseri, Ehsan

Abstract

Provided is a composition including a dispersion medium including: an aqueous solution; a first active ingredient; a flavor agent; and a first type of polymer; and a dispersed phase including: a population of particles, each particle including: a core including: a second active ingredient a second type of polymer; and an aqueous solution; a shell, substantially surrounding the core, the shell including: a third type of polymer; a plurality of lipophilic carriers; and a third active ingredient; and a plurality of emulsifying agents.

IPC Classes  ?

  • A61K 9/10 - DispersionsEmulsions
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 9/08 - Solutions
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 31/539 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more oxygen atoms in the same ring, e.g dioxazines
  • A23L 33/155 - Vitamins A or D
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3